Mochida schedules October 30 results for Mochida stock

Published on 10/20/2026 at 19:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mochida had a JPY 107.9 billion market value and a 2.70 percent yield on October 14, 2026. Mochida stock costs EUR 18.25 on October 20, 2026.

Reporting date and market facts

Mochida's next earnings report is scheduled for October 30, 2026.
Mochida carried a JPY 107.9 billion market value and a 2.70 percent dividend yield on October 14, 2026.
Mochida stock costs EUR 18.25 at Lang & Schwarz on October 20, 2026 at 7:32 p.m. CEST.
The company reported JPY 116.95 billion in fiscal-year 2026 revenue.

Mochida, JP3922800002, Illustration mit AI erstellt.

Mochida Pharmaceutical (ISIN JP3922800002) is scheduled to publish its next earnings report on October 30, 2026, according to TradingView. The stock was trading at EUR 18.25 at Lang & Schwarz on October 20, 2026 at 7:32 p.m. CEST.

October 30 is the next date

The scheduled report gives investors the next fixed checkpoint for Mochida's fiscal 2026 performance. TradingView identifies October 30, 2026 as the company's next earnings date, putting the announcement within the next reporting cycle.

Valuation stays in view

Barron's listed Mochida's average price target at JPY 3,200 from one rating on October 14, 2026. The same page showed a JPY 2,929 to JPY 3,965 52-week range, a JPY 107.9 billion market value and a 2.70 percent dividend yield.

Revenue provides the operating baseline

For fiscal year 2026, Mochida reported revenue of JPY 116.95 billion, while the latest available fiscal-year comparison on the same market page showed sales growth of 11.21 percent. The business spans pharmaceuticals and healthcare products, including prescription medicines, diagnostics and skincare products.

What does October 30 add?

The report can update the revenue baseline and clarify whether earnings momentum is carrying into the current fiscal year. Mochida's latest quarter generated JPY 31.72 billion in revenue and JPY 3.18 billion in net income for the quarter ended June 30, 2026, figures also reflected in the company's current financial reporting record.

Stock position and next step

Mochida is listed on the Tokyo Stock Exchange under ticker 4534 and operates in the healthcare and specialty pharmaceutical industry. The October 30 report is the next dated event for the stock, while the JPY 3,200 average target provides a valuation reference in the home-market currency.

Mochida was trading at EUR 18.25 at Lang & Schwarz on October 20, 2026 at 7:32 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Mochida stock.